Publication | Closed Access

Clinical evaluation of plasma des-?-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes

HepatologyHepatocellular CarcinomaMarker ProteinMedicineHistopathologyPathologyLiver CancerPlasma Des-OncologyRadiation OncologyTumor MicroenvironmentCancer Research